Jump to navigation
Activate excellence. Activate innovation. Activate success.
Aquinox Pharmaceuticals, Inc.
A clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation and cancer.
News and Media
March 7, 2014
Aquinox Pharmaceuticals Prices Initial Public Offering
December 17, 2013
Aquinox Pharmaceuticals commences Phase 2 clinical trial of AQX-1125 in Chronic Obstructive Pulmonary Disease